top of page
Website Banner.jpg

Kanad Hospital Neonatal-Perinatal Medicine Services & In cooperation with the

College of Medicine and Health Sciences, UAEU, under the patronage of the

Dean of the Faculty of Medicine, The respected Prof. Dr. Juma Al Kabbi.



It is our pleasure to invite you to attend Kanad Hospital 2nd Annual Neonatal - Perinatal Medicine Scientific Meeting that will be held on November 18 - 19, 2022 in Radisson Blu Hotel, Al Ain, Abu Dhabi, UAE.

The programme will cover a broad range of topics such as latest trends within the field of fetal medicine and advances of management within Neonatology: Invasive & Non-Invasive, Neonatal Ventilation, Cardiology, Neonatal Infection, Neonatal Encephalopathy, Neonatal Resuscitation, Neonatal GI, Neonatal Surgery, Neonatal Orthopedics, Genetic & Metabolic Disorders.

The conference will offer a superb opportunity for healthcare professionals to share their best practices, to network within the same group of interest, and to create and strengthen clinical collaborations.

We look forward in welcoming you to this conference!

Moh’d Yousef Khalil2.png

Dr. Moh’d Yousef Khalil

Conference Chairman

Pediatrics/Neonatology Consultant


Dr. Fares Chedid

Conference Co-Chairman

Pediatrics Neonatology Consultant
Department Head

Nicholas Hoque.png

Dr. Nicholas Hoque

Organizing Committee
Pediatrics/Neonatology Consultant



  • Explore the latest trends within the field of fetal


  • Advances of Management within Neonatology:
    Invasive & Non-Invasive Neonatal Ventilation
    Neonatal Infection
    Neonatal Encephalopathy
    Neonatal Resuscitation
    Neonatal GI
    Neonatal Surgery
    Neonatal Orthopedics
    Genetic & Metabolic Disorders



  • Neonatologists

  • Pediatricians

  • Family Medicine Clinicians

  • Fetal Medicine Clinicians

  • General Practitioners

  • Midwives

  • Nurses

  • Obstetricians

  • Pharmacists

  • Radiologists

  • Anesthesiologists

  • Educators

  • Researchers

  • Residents/Fellows/Interns

  • Students

5% VAT Exclusive




AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolic Diseases and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. 

They are focused on creating genuinely innovative medicines and improving access to them. In this way, they deliver the greatest benefit to patients, healthcare systems and societies globally. They have three priorities designed to deliver our growth through innovation strategy - Accelerate Innovative Science; Deliver Growth and Therapy Area Leadership; and Be a Great Place to Work.

At AstraZeneca, sustainability is part of our DNA, embedded in everything they do, from the lab to the patient. Working in partnership with all the stakeholders, they are harnessing the power of science and innovation to deliver life-changing medicines in a way that is respectful of our planet.

Chiesi Logo - 1.Primary.png

We are an international group based in Parma, research-oriented, with over 85 years of experience, present in 30 countries. The Chiesi Group researches, develops and markets innovative drugs in three specific areas: AIR (products and services in the respiratory field, from infants to adults), RARE (innovative solutions and personalized services to improve the quality of life of patients with rare and ultra-rare diseases) and CARE (products and services to support specialist care, personal care and well-being).


bottom of page